BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1082382)

  • 1. Experimental study of the role of inactivated vaccine in two-step vaccination against smallpox.
    Marennikova SS; Macevic GR
    Bull World Health Organ; 1975; 52(1):51-6. PubMed ID: 1082382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].
    Stickl H; Hochstein-Mintzel V; Mayr A; Huber HC; Schäfer H; Holzner A
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2386-92. PubMed ID: 4426258
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].
    Ma FB; Zheng L; Bi C; Tao H; Zhou YL; Zhang JL; Tang FY; Xie P; Zheng CZ; Peng WB; Jiang RJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):113-5. PubMed ID: 12697111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [MVA-vaccine in primovaccination against smallpox after the age of three (author's transl)].
    Schröter W; Stickl H; Idel H; Schlipköter HW
    Zentralbl Bakteriol Mikrobiol Hyg B; 1980 Sep; 171(4-5):309-19. PubMed ID: 7456853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge.
    Islam AF; Walkden-Brown SW; Groves PJ; Underwood GJ
    Aust Vet J; 2007 Sep; 85(9):348-55. PubMed ID: 17760936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.
    Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW
    Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Historical review of smallpox, the eradication of smallpox and the attenuated smallpox MVA vaccine].
    Mayr A
    Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):322-8. PubMed ID: 10507180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response of kori bustards (Ardeotis kori) and houbara bustards (Chlamydotis undulata) to live and inactivated Newcastle disease vaccines.
    Bailey TA; Wernery U; Samour JH; Naldo JL
    J Zoo Wildl Med; 1998 Dec; 29(4):441-50. PubMed ID: 10065854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two kinds of smallpox vaccine: CVI-78 and calf lymph vaccine. I. Clinical and serologic response to primary vaccination.
    Wesley RB; Speers WC; Neff JM; Ruben FL; Lourie B
    Pediatr Res; 1975 Aug; 9(8):624-8. PubMed ID: 1098000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses.
    Sohn YM; Tandan JB; Yoksan S; Ji M; Ohrr H
    Vaccine; 2008 Mar; 26(13):1638-43. PubMed ID: 18294743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques.
    Edghill-Smith Y; Venzon D; Karpova T; McNally J; Nacsa J; Tsai WP; Tryniszewska E; Moniuszko M; Manischewitz J; King LR; Snodgrass SJ; Parrish J; Markham P; Sowers M; Martin D; Lewis MG; Berzofsky JA; Belyakov IM; Moss B; Tartaglia J; Bray M; Hirsch V; Golding H; Franchini G
    J Infect Dis; 2003 Oct; 188(8):1181-91. PubMed ID: 14551889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization against smallpox.
    Hochstein-Mintzel V; Stickl H; Huber HC
    Dev Biol Stand; 1976; 33():260-6. PubMed ID: 182585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a combined parapox/BVD vaccine.
    Büttner M
    Dev Biol Stand; 1986; 65():221-6. PubMed ID: 3030862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking advantage of the positive side-effects of smallpox vaccination.
    Mayr A
    J Vet Med B Infect Dis Vet Public Health; 2004 Jun; 51(5):199-201. PubMed ID: 15330977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A; Baljer G; Wagner C; Sailer J
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):206-18. PubMed ID: 2990123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.